Email Alert | RSS

Journal of Tuberculosis and Lung Disease ›› 2023, Vol. 4 ›› Issue (1): 66-71.doi: 10.19983/j.issn.2096-8493.20230001

• Original Articles • Previous Articles     Next Articles

Diagnostic value of loop-mediated isothermal amplification method in non sputum or smear negative pulmonary tuberculosis

Zeng Fang1, Zhu Xiaoxia2, Gong Rui2, Liu Chuanhong3, Shi Dejun4, Zhao Ling2, Yang Song5()   

  1. 1Specialist Clinic, Wushan County Hospital of TCM, Chongqing 404700, China
    2Department of Infectious Disease, Wushan County People’s Hospital of Chongqing, Chongqing 404700, China
    3Department of Respiratory Medicine, Wushan County People’s Hospital of Chongqing, Chongqing 404700, China
    4Department of Clinical Laboratory, Wushan County People’s Hospital of Chongqing, Chongqing 404700, China
    5Comprehensive Internal Medicine, Chongqing Public Health Medical Center, Chongqing 400030, China
  • Received:2022-11-04 Online:2023-02-20 Published:2023-02-09
  • Contact: Yang Song E-mail:yangsong5@aliyun.com
  • Supported by:
    Chongqing Science and Health Joint Medical Research(2020FYYX243)

Abstract:

Objective: To explore the diagnostic value of loop-mediated isothermal amplification (LAMP) in detecting bronchoalveolar lavage fluid (BALF) in non sputum or smear negative pulmonary tuberculosis. Methods: The prospective study method was adopted, with the subjects being the sputum free or smear negative suspected pulmonary tuberculosis patients who were admitted to Wushan County People’s Hospital of Chongqing from April 2021 to April 2022 and met the inclusion criteria; they all brushed under bronchoscope for fluorescent staining microscopy (referred to as “smear”), and took BALF for LAMP and GeneXpert MTB/RIF (referred to as “Xpert”) to detect Mycobacterium tuberculosis complex DNA. With the final clinical diagnosis as the reference standard, the detection efficiency of the three methods was analyzed. Results: A total of 232 patients were included in the study. The patients were divided into smear negative/sputum free pulmonary tuberculosis patients (139 cases) and non tuberculosis pulmonary disease patients (93 cases) according to the final clinical diagnosis. The positive rates of LAMP, Xpert and smear in 232 patients with suspected pulmonary tuberculosis were 43.53% (101/232), 43.97% (102/232) and 8.19% (19/232), respectively. Taking the final clinical diagnosis as the reference standard, the detection sensitivity of LAMP, Xpert and smear for sputum free or smear negative pulmonary tuberculosis were 71.94% (100/139), 72.66% (101/139) and 13.67% (19/139) respectively; the specificity were 98.92% (92/93), 98.92% (92/93) and 100.00% (93/93) respectively; the diagnostic coincidence rates were 82.76% (192/232), 83.19% (193/232) and 48.28% (112/232); the Yoden index were 0.709, 0.716 and 0.137, respectively. Conclusion: The detection efficiency of LAMP for BALF in patients with sputum free or smear negative pulmonary tuberculosis is basically consistent with that of Xpert, significantly improving the early diagnosis rate; in addition, LAMP is easy to operate and cheap, which is more suitable for the promotion and application of grass-roots medical institutions.

Key words: Tuberculosis, pulmonary, Bronchoalveolar lavage fluid, Nucleic acid amplification techniques, Evaluation studies

CLC Number: